Evaluation of a newly developed quantitative determination kit for tumor marker CA15‐3 with chemiluminescent assay

BACKGROUND: Tumor marker carbohydrate antigen 15‐3 (CA15‐3) is used as a biomarker to aid to diagnose and monitor the prognosis of breast cancer patients. A new quantitative determination kit for CA15‐3 with chemiluminescent assay was developed by Xiamen InnoDx Biotech Co., Ltd, China. Therefore, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Peihua, Ye, Huiming, Liu, Jiangwu, Jin, Hongwei, Lin, Yongzhi, Yan, Shuidi, Yu, Yang, Gao, Lei, Xu, Feihai, Zhang, Zhongying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811926/
https://www.ncbi.nlm.nih.gov/pubmed/28233344
http://dx.doi.org/10.1002/jcla.22158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811926/
https://www.ncbi.nlm.nih.gov/pubmed/28233344
http://dx.doi.org/10.1002/jcla.22158

Ejemplares similares